Ramtin Agah - Mar 10, 2022 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Role
Chief Medical Officer, Director
Signature
/s/ Ramtin Agah
Stock symbol
RNXT
Transactions as of
Mar 10, 2022
Transactions value $
$0
Form type
4
Date filed
3/14/2022, 04:24 PM
Previous filing
Oct 4, 2021
Next filing
Jun 9, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNXT Employee Stock Option (right to buy) Award $0 -21.4K -50% $0.00 21.4K Mar 10, 2022 Common Stock 21.4K $3.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest in 48 equal monthly installments beginning on September 26, 2021.